|
Thursday, November 16, 2017
Print Current Session:
 |
|
|
Thursday
SESSION 60:
NEW DEVELOPMENTS AND DEVICES FOR LOWER EXTREMITY STENTS, BALLOONS, ATHERECTOMY AND STENT-GRAFTS; TECHNICAL ADVANCES TO IMPROVE THEIR USE
|
|
| SESSION 60 SCHEDULE | |
| 2:00 PM - 2:05 PM | Are There Late Problems With Current DESs And DCBs For The Treatment Of SFA Lesions: Can Improved Technology With Sustained Release From Drug Reservoirs Overcome Them: What Else Offers Promise |
|
Presenter(s):George L. Adams, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Status Of Bioresorbable Stents To Treat Lower Extremity Lesions: 3-Year Results Of The ESPRIT Trial: Advantages, Limitations And Future Prospects |
|
Presenter(s):Michael D. Dake, MD / Michael R. Jaff, DO Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Value And Availability In The US Of DESs To Treat BTK Popliteal And Crural Arteries: Indications And Future Prospects |
|
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | A New 2-Component Tigris Stent (Gore) For Treatment Of Lower Extremity Occlusive Lesions: Advantages And Limitations |
|
Presenter(s):Thomas Zeller, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Advantages Of Swirling Flow Induced By The BioMimics 3D Helical Stent (Veryan): How Does It Work And 2-Year Results Of A RCT vs. Standard Stents |
|
Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | A New Different DCB – The Luminor (iVascular) For Treating BTK Popliteal And Crural Artery Lesions Causing CLTI: What Makes It Different And Favorable 1-Year Results |
|
Presenter(s):Vicente Riambau, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Value To Date And Potential Value Of The Bullfrog Microinfusion Balloon Device (Mercator MedSystem) For Better Local Drug Delivery Into The Vessel Wall To Treat Arterial Lesions: 1-Year Plus Results Of The DANCE Trial With Dexamethasone Delivery |
|
Presenter(s):George L. Adams, MD / Mahmood Razavi, MD Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | 2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem-Pop And BTK Lesions Demonstrates Safety, Efficacy And Cost Effectiveness Of Tack Device (Intact Vascular) In Repairing Focal PTA Dissections |
|
Presenter(s):Christian Wissgott, MD / Marianne Brodmann, MD / Marc Bosiers, MD / Thomas Zeller, MD / Michael R. Jaff, DO Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | What Special Forces Do Infrapopliteal Arteries Exert On Stents And Why Will The Tack Device (Intact Vascular) Be Better Able To Resist These Forces Than Stents |
|
Presenter(s):John H. Rundback, MD, FSIR, FAHA, FSVMB Location: Grand Ballroom West, 3rd Floor |
|
| View Slides in PDF | |
| 2:54 PM - 3:02 PM | Panel Discussion |
| 3:03 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 60 | |
| previous | next |